U.S. lawmakers question Mylan’s Medicaid EpiPen rebates

5 months ago Comments Off on U.S. lawmakers question Mylan’s Medicaid EpiPen rebates

Sept 2 (Reuters) – Two key U.S. congressional committee members on Friday called for an investigation into whether Mylan NV, under fire for raising the price of its EpiPen device, overcharged the government’s low-income healthcare program for the allergy treatment.


Reuters: Financial Services and Real Estate